On the Significance of Glucolysis for Cancer Growth, With Special Reference to Morris Rat Hepatomas 2
The DOI matches its Crossref record.
Abstract
Anaerobic fermentation (glycolysis of glucose) was measured in a progressive growth spectrum of normal and host rat livers (zero net growth) through very slowly growing, slowly growing, intermediately growing, and rapidly growing lines of Morris rat hepatomas, maintained as slices in Krebs-Ringer bicarbonate-glucose-pyruvate medium at 37 C with 5% CO2 in N2 as gas phase. All hepatoma lines, including even the most slowly growing, showed glucose fermentation values in excess of those of normal or host rat livers. A continuous, positive correlation was observed between in vivo growth rate and in vitro anaerobic glucolytic potential; also, of equal importance, Km-glucose (concentration of glucose required for half-maximum rate of fermentation) and degree of inhibition by the anti-insulin stilbestrol decreased with increasing growth rate. Recent data of Gullino are cited which provide overwhelming evidence as to the actuality of in vivo fermentation of glucose to lactate by slow-growing hepatomas of the Morris series, compared to in vivo consumption of lactate normally observed with livers. The results reported make clear that a dominant biochemical difference between a normal metabolism and one characteristic of even the lowest degree of malignancy studied involves a critical, however small, increase in glucolytic capacity over that in the normal tissue of origin, in this instance, liver. Progression in malignant growth capacity is associated with increasing fermentation capacity. These results and conclusions confirm and extend the well-known findings of Otto Warburg over the past 40 years and our similar findings made with mouse melanoma spectra and Sanford-Earle tissue culture spectra, and, as reported here, also in the Hilf rat mammary tumor spectrum. Implications of these findings for chemotherapy and hyperthermy therapy of cancers are briefly indicated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
(1989) · PubMed · Cited by 1,639
Cancer as a metabolic disease: implications for novel therapeutics
Seyfried, T. N., Flores, R. E., Poff, A. M., & D'Agostino, D. P. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt480 · Cited by 472
Pedersen, P. L. (2007) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-007-9094-x · Cited by 425
Positron emission tomography scanning in the evaluation of hepatocellular carcinoma
Khan, M. A., Combs, C. S., Brunt, E. M., Lowe, V. J., Wolverson, M. K., Solomon, H., Collins, B. T., & Bisceglie, A. M. D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80248-2 · Cited by 417
Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species 1
Brand, K. A., & Hermfisse, U. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.5.9141507 · Cited by 401
Metadata
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 1967-06
- Volume
- 38
- Issue
- 6
- Pages
- 839-63
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2250044440
- Cited by
- 129
- References
- 0
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: On the Significance of Glucolysis for Cancer Growth, With Special Reference to Morris Rat Hepatomas 2. https://app.cochat.ai/papers/10.1093/jnci/38.6.839
- The paper
- On the Significance of Glucolysis for Cancer Growth, With Special Reference to Morris Rat Hepatomas 2. (1967). JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/38.6.839
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.